Dissertation > Excellent graduate degree dissertation topics show

The Immune Mechanism and Effect of Rosiglitazone in Adults with Latent Autoimmune Diabetes (LADA)

Author: YangZhiFang
Tutor: ZhouZhiGuang
School: Central South University
Course: Internal Medicine
Keywords: Diabetes , autoimmune , occult Rosiglitazone Islet function Treatment Lymphocyte CD4 ~ CD25 ~ FOXP3 CD4 ~
CLC: R587.1
Type: PhD thesis
Year: 2007
Downloads: 112
Quote: 0
Read: Download Dissertation


Part 1 Rosiglitazone preserves isletβcellfunction of adult-onset latent autoimmune diabetesin 3 years follow-up studyObjective: To investigate the effects of rosiglitazone on isletβcellfunction and the strategy for treating LADA.Methods: LADA patients, defined as GAD-Ab positive, with a fastingC-peptide (FCP) of 0.2nmol/L or more, were enrolled and evaluated to bedivided to receive oral hypoglycemic agents or insulin therapy. Then,those patients in oral hypoglycemic agents group randomly assigned toreceive sulfonylureas (SUs group, n=15) or rosiglitazone (RSG group, n=15) therapy, metformin added if needed. Those patients in insulin groupwere randomly assigned to receive subcutaneous insulin alone (n=12) orrosiglitazone combined with insulin (n=12). The DQA1 and DQB1genotypes were analysed with sequence-based typing. Plasma glucose,HbA1c, fasting C-peptide (FCP) and C-peptide after 2 h 75-g glucoseload (PCP) were determined every 6 months. GAD-Ab and C-peptidewere measured with radioligand assay and radioimmune assayrespectively.Results: 1) During 3 years’ follow-up, noβcell function failure occurredin the patients of group received oral hypoglycemic agents. The HbA1clevels (5.95±0.57% vs 8.31±2.75%, P<0.05)and FCP levels (0.69±0.27nmol/L vs 0.83±0.24nmol/L, P<0.05) were lower in RSG group patientsin the first 6 months, accompanying with the improvement ofHOMA2-IR(1.71±0.52mmol~*mU/L~2 vs 2.19±0.79mmol~*mU/L~2, P<0.05). The PCP and△CP (△CP=PCP-FCP) levels in RSG group patientssustained, which were higher than those in SUs group (PCP,3.15±1.95nmol/L vs 1.99±0.76 nmol/L, P<0.05), (△CP, 2.45±1.87nmol/L vs 1.32±0.70 nmol/L, P<0.05) at 18 months, then the differences wenton. HOMA2-%B in RSG group were higher than those in SUs group inthe 18th month (82.78±52.9% vs 52.5126.77%, P<0.05) and in the 36thmonth (73.46±36.87% vs 43.27±30.48%, P<0.05).2) During 3 years’ follow-up,βcell function failure occurred in 9LADA patients of group received insulin. The FCP levels(0.34±0.28nmol/L vs 0.54±0.31 nmol/L, P<0.05) in INS+RSG groupwere decreased until the 36th month. However, the FCP levels(0.38±0.29nmol/L vs 0.57±0.46nmol/L, P<0.05)in INS group showedapparent decrease after the 6th month. The FCP levels in INS+RSG groupwere higher than those in INS group after the 12th month. The PCP levelsand△CP levels in INS+RSG group sustained, whereas the PCP levels(0.71±0.72nmol/L vs 1.35±0.94nmol/L, P<0.01) and△CP levels(0.44±0.58nmol/L vs 0.78±0.70nmol/L, P<0.05) in INS group weredecreased after the 12th month. The PCP levels (after the 12th month)and△CP levels (after the 18th month) in INS+RSG group were higherthan those in INS group.Conclusions: Rosiglitazone had beneficial effects on isletβcell functionin LADA patients. Part 2 The CD4~+ regulatory T cells in adults with latentautoimmune diabetesObjective: To study the percentage of peripheral blood CD4~+CD25~+ Tcells and the expression of FOXP3 mRNA in the patients with latentautoimmune diabetes in adults (LADA).Methods: Fresh peripheral blood samples were obtained from 67 patientswith LADA, 30 patients with type 2 diabetes and 30 matched healthynondiabetic control subjects without diabetic family history. Two-colorstaining (anti-CD4, anti-CD25, anti-CD3, anti-CDS) flow cytometricanalysis was employed to measure the CD4~+CD25~+ T Cells of peripheralblood. The CD4~+ T cells were purified with anti-CD4-Dynal magneticbeads and Detach-a-Bead antibodies. Using real time-PCR tested theexpression of FOXP3 mRNA in CD4~+ T Cells.Results: 1) Patients with LADA had higher percentage of CD4~+CD25~+ Tcells (4.1±1.9% vs 2.8±1.5%, P<0.01) and CD4~+CD25~+of CD4~+ T cells(11.9±5.0% vs 8.2±3.7%, P<0.01) and CD8~+ T cells (24.6±6.8% vs19.4±7.1%, P<0.01 ) and lower of CD4~+/CD8~+ ratio(1.5±0.5 vs 1.9±0.6,P<0.01) in comparison with control subjects.2) Patients with LADA had lower expression of FOXP3 mRNAin CD4~+ T cells compared to the control subjects (0.52-fold, P<0.01,n=10).Conclusion: Though the percentage of CD4~+CD25~+ T cells elevated, theexpression of FOXP3 mRNA in CD4~+ T cells was lower in patients withLADA. The regulatory T cells may be defective in LADA patients. Part 3 Rosiglitazone upregulates FOXP3 mRNA expressionof CD4~+ T cells in adults with latent autoimmune diabetesObjective: To investigate the effect of rosiglitazone on the CD4~+regulatory T cells in the patients with latent autoimmune diabetes inadults(LADA).Methods: The CD4~+ T cells from LADA patients were isolated, andexpression of FOXP3 mRNA, along with PPAR_γmRNA and TGF-β1mRNA, was determined. The effect of rosiglitazone on CD4~+ T cells wasmeasured in vivo before and after rosiglitazone treatment and in in vitrocultures for 48h. Cell viability was assessed by tetrazolium salt3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazoliumbromide bromide(MTT) assay. The proliferation assay was assessed with [~3HI thymidine.Two-color staining (anti-CD4, anti-CD25) flow cytometric analysis wasemployed to measure the percentage of CD4~+CD25~+ T cells of peripheralblood.Results: PPAR_γmRNA is expressed in peripheral CD4~+T Lymphocytes.1) Rosiglitazone inhibited PHA-induced human CD4~+T cell activation indose dependent fashion. The percentage of CD4~+CD25~+ T cells showedno significant change after the peripheral blood culture with 1uM and10uM rosiglitazone. The concentration of 10uM rosiglitazone inducedFOXP3 mRNA expression in in vitro cultures (3.27fold, P<0.05),whereas TGF-β1 mRNA expression did not change. Furthermore, onlythe concentration of 1uM rosiglitazone promoted FOXP3 mRNAexpression if adding IL-2 (10U/mL) in in vitro cultures (3.48fold,P<0.05).2) FOXP3 mRNA expression was significantly elevated in the CD4~+Tcells of LADA patients receiving rosiglitazone treatment for 6 months(2.2fold, P<0.05), although there were no increase in the CD4~+CD25~+ T cells.Conclusion: Rosiglitazone promotes FOXP3 mRNA expression inCD4~+ T cells in vivo and in vitro, improving the defective of theregulatory T cells.

Related Dissertations

  1. Studies on the Synthesis and Technology of Dipentaerythritol and Its Derivative,TQ223.164
  2. Preparation and Performance of Molecular Imprinted Polymers for Rhodamine-B and Rhodamine-6G,O631.3
  3. The Clinical Observation of Curative Effect Made by Differential Treatment of Refractory Thrombocytopenic Purpura,R259
  4. The Clinical Observation of the Lupus Detoxification Pill on Treating the Remission of Systemic Lupus Erythematosus,R259
  5. Effects of acupuncture on stroke recovery associated with depression and physical disabilities,R246.6
  6. The Preliminary Studies on Characteristics of HCV Quasispecies Variation and Its Immune Escaping Mechanism,R392.1
  7. Platelet parameters in patients before and after acute myocardial infarction,R542.22
  8. Professor Zhang Shuwen academic thinking,and 59 cases of Chinese and Western medicine combined with clinical research for diagnosis and treatment of acute pancreatitis,R249.2
  9. TRAIL in the regulation of tumor invasion CD4 ~ CD25 ~ Treg,R730.2
  10. Study on Nitrogen Removal by Soil Aquifer Treatment Process That Enhanced Nature Reoxygenation and Effective Volume,X703
  11. Pd-based cathode catalysts of direct methanol fuel cell,O643.36
  12. Study on Effect and Mechanisms of Hot Air Combined with MeJA on Quality Maintenance in Loquat Fruit,TS255.3
  13. Selection and Optimization of Control Technics in CODCr and Colority of the Refined Cotton Wastewater Treatment Process in a Refined Cotton Enterprise in Rudong, Jiangsu Province,X791
  14. Study on Drying Processing and Sterilization on Spinach,TS255.52
  15. Experimental Study of Improved UASB Reactor Treatment of Organic Wastewater,X703
  16. Mechanisms of Alleviating Effect of Seed Soaking with Soybean Isoflavones on Glycine Max, Salt-born Glycine Soja and Their Hybrid Seedlings under Salt Stress,S565.1
  17. Study on Characteristics of Morphology Anatomy and Physio-Biochemistry of Two Ecotype Varieties Cucumber Leggy Seedilings,S642.2
  18. Study on Key Technology and Its Physiological Basis of Virus Elimination and Rapid Propagation of Phalaenopsis,S682.31
  19. Chen Tongyun teacher academic thinking and clinical experience and treatment prescription acne hair cut,R249.2
  20. The Influence in Different Route of Medication with Vitamin A on CD4~+CD25~+ Regulatory T Cell and Cell Factor of IL-4、 IFN-γ in a Rat Persistent Asthma Model,R562.25
  21. Therapeutic Effects of TACI-Ig on Systemic Lupus Erythematosus-like Mouse Model Induced by Active Chromatin Isolated from ConA-actived Lymphocytes,R593.241

CLC: > Medicine, health > Internal Medicine > Endocrine diseases and metabolic diseases > Islet disease > Diabetes
© 2012 www.DissertationTopic.Net  Mobile